The Efko group of companies will build a biotechnology group in the United Arab Emirates to produce sweet protein in this country using its own technology. In the summer, the company received the necessary certificates in the country to produce brazzein protein. Investments in the project will amount to 500 million dollars, according to the company’s press service.
In August, the company announced the completion of certification of its own sweet proteins and announced the start of product deliveries to the United Arab Emirates.
One gram of this protein has the same sweetness as 2 kg of normal sugar. At the same time, it does not cause an insulin response in the blood, which is important for those suffering from diabetes.
On February 29, company representatives signed an agreement on the design of a protein production facility using Efko technology.
Efko intends to supply its product to the Middle East market. The future cluster will be one of the largest in the world. The company will take brazein production to an industrial level.
At the end of December, Efco’s first Applied Research Center (ARC) in the Middle East began operations in Dubai. They invested 3 million dollars in its launch.
Previously, Efko signed an agreement with the government of the Belgorod region for the construction of a plant for the production of feed enzymes. The group’s investments in this project could reach up to 9.4 billion rubles.
Author:
Natalia Gormaleva
Source: RB
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
